FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martin Stangel

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Procedures

Immunohistochemistry

Co-author Network

Publications

TOP 3
Martin Stangel; Olaf Stüve; Sten Fredrikson; Edgar Meinl; Axel Petzold; Hayrettin Tumani
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
Sarah Knippenberg; Sonja Körner; Reinhard Dengler; Viktoria Gudi; Refik Pul; Klaus Jan Rath; Thomas Skripuletz; Martin Stangel; Nadine Thau; Susanne Petri
CDP-choline is not protective in the SOD1-G93A mouse model of ALS.
N Cieplik; Martin Stangel; O Bachmann
[Neurological complications of inflammatory bowel diseases].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martin Stangel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martin Stangel; Olaf Stüve; Sten Fredrikson; Edgar Meinl; Axel Petzold; Hayrettin Tumani
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
Nature reviews. Neurology 2013;9(5):267-76.
2013: Sarah Knippenberg; Sonja Körner; Reinhard Dengler; Viktoria Gudi; Refik Pul; Klaus Jan Rath; Thomas Skripuletz; Martin Stangel; Nadine Thau; Susanne Petri
CDP-choline is not protective in the SOD1-G93A mouse model of ALS.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2013;14(4):284-90.
2013: N Cieplik; Martin Stangel; O Bachmann
[Neurological complications of inflammatory bowel diseases].
Der Nervenarzt 2013;84(2):190-6.
2013: Anna-Lena Boeck; Eva Bültmann; Kais Hussein; Terence Krauß; Frank Logemann; Corinna Trebst; Martin Stangel
Ovarectomy despite Negative Imaging in Anti-NMDA Receptor Encephalitis: Effective Even Late.
Case reports in neurological medicine 2013;2013():843192.
2013: Thomas Skripuletz; Elke Voss; Katharina Bauer; Wolfgang Baumgärtner; Katharina Berger; Viktoria Gudi; Diane Hackstette; Markus Kipp; Refik Pul; Martin Stangel
Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
Brain : a journal of neurology 2013;136(Pt 1):147-67.
2013: Martin Stangel; Ulrich Baumann; Michael Borte; Maria Fasshauer; Manfred Hensel; Dörte Huscher; Wilhelm Kirch; David Pittrow; Marcel Reiser; R Gold
Treatment of neurological autoimmune diseases with immunoglobulins: first insights from the prospective SIGNS registry.
Journal of clinical immunology 2013;33 Suppl 1():S67-71.
2012: Vikramjeet Singh; Karelle Bénardais; Elke Verena Voss; Martin Stangel
Effects of 2-chlorodeoxyadenosine (Cladribine) on primary rat microglia.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2012;7(4):939-50.
2012: Elke V Voss; Martin Stangel
Nervous system involvement of connective tissue disease: mechanisms and diagnostic approach.
Current opinion in neurology 2012;25(3):306-15.
2012: Vanessa Herder; Karl Rohn; Dirk Schaudien; Martin Stangel; Wolfgang Baumgärtner; Florian Hansmann; Andreas Beineke
Cuprizone inhibits demyelinating leukomyelitis by reducing immune responses without virus exacerbation in an infectious model of multiple sclerosis.
Journal of neuroimmunology 2012;244(1-2):84-93.
2012: Refik Pul; Vikramjeet Singh; Thomas Skripuletz; Ute Diederichs; Niklas Garde; Franco Morbiducci; Corinna Trebst; Elke Verena Voss; Jelena Škuljec; Martin Stangel
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
PloS one 2012;7(12):e51867.
2012: Martin Stangel
Neurodegeneration and neuroprotection in multiple sclerosis.
Current pharmaceutical design 2012;18(29):4471-4.
2012: Corinna Trebst; Paul Bronzlik; Jan T Kielstein; Bernhard M W Schmidt; Martin Stangel
Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis.
Blood purification 2012;33(1-3):1-6.
2011: Corinna Trebst; Elke Verena Voss; Uwe K Zettl; Mazen Abu-Mugheisib; Peter Raab; Paulus Rommer; Martin Stangel
Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.
Nature reviews. Neurology 2011;7(12):688-98.
2011: Thomas Skripuletz; Viktoria Gudi; Diane Hackstette; Martin Stangel
De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Histology and histopathology 2011;26(12):1585-97.
2011: Thomas Skripuletz; Jelena Skuljec; Corinna Trebst; Elke Voss; Lisa Grote; Viktoria Gudi; Elvira Miller; Darius Moharregh-Khiabani; Refik Pul; Martin Stangel
Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system.
Brain, behavior, and immunity 2011;25(8):1592-606.
2011: V Herder; Thomas Skripuletz; Martin Stangel; W Baumgärtner; F Hansmann; Andreas Beineke
Lack of cuprizone-induced demyelination in the murine spinal cord despite oligodendroglial alterations substantiates the concept of site-specific susceptibilities of the central nervous system.
Neuropathology and applied neurobiology 2011;37(6):676-84.
2011: Refik Pul; Thomas Skripuletz; Jelena Škuljec; Niklas Garde; Darius Moharregh-Khiabani; Elke Verena Voss; Martin Stangel
Glatiramer acetate modulates TNF-α and IL-10 secretion in microglia and promotes their phagocytic activity.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2011;6(3):381-8.
2011: Thomas Skripuletz; Refik Pul; Ulrich Wurster; Dietrich Peest; Reinhard Dengler; Martin Stangel
B-cell lymphoma infiltration of cerebrospinal fluid with minimal symptoms and benign course.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2011;18(7):978-80.
2011: Martin Stangel; R Gold
[Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010].
Der Nervenarzt 2011;82(4):415-6, 418, 420 passim.
2011: Elke Voss; Corinna Trebst; Peter Raab; Martin Stangel
Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis.
Therapeutic advances in neurological disorders 2011;4(2):123-34.
2011: Refik Pul; Richard Dodel; Martin Stangel
Antibody-based therapy in Alzheimer's disease.
Expert opinion on biological therapy 2011;11(3):343-57.
2011: Sabine Lindquist; Martin Stangel
Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine.
Neuropsychiatric disease and treatment 2011;7():341-9.
2011: Viktoria Gudi; Darius Moharregh-Khiabani; Thomas Skripuletz; Jelena Škuljec; Elke Voss; Kirsten Wissel; Sabine Wolter; Özlem Yildiz; Konstantin Frichert; Martin Stangel
Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming.
PloS one 2011;6(7):e22623.
2011: Jelena Skuljec; Hui Sun; Corinna Trebst; Karelle Bénardais; Alexandra Kotsiari; Darius Moharregh-Khiabani; Refik Pul; Daniela Ragancokova; Martin Stangel
CCL5 induces a pro-inflammatory profile in microglia in vitro.
Cellular immunology 2011;270(2):164-71.
2010: P N Koutsoudaki; Herbert Hildebrandt; V Gudi; Thomas Skripuletz; J Škuljec; Martin Stangel
Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV.
Neuroscience 2010;171(1):235-44.
2010: Alexandra Kotsiari; Elke Verena Voss; Refik Pul; Thomas Skripuletz; Daniela Ragancokova; Corinna Trebst; Martin Stangel
Interferon-β treatment normalises the inhibitory effect of serum from multiple sclerosis patients on oligodendrocyte progenitor proliferation.
Neuroscience letters 2010;485(2):107-11.
2010: Thomas Skripuletz; Elvira Miller; Darius Moharregh-Khiabani; Alexander Blank; Refik Pul; Viktoria Gudi; Corinna Trebst; Martin Stangel
Beneficial effects of minocycline on cuprizone induced cortical demyelination.
Neurochemical research 2010;35(9):1422-33.
2010: Thomas Skripuletz; Refik Pul; Julian Herrmann; Eva Bueltmann; Ulrich Wurster; Martin Stangel; Corinna Trebst
Meningeal carcinomatosis from penile squamous cell carcinoma.
Journal of neuro-oncology 2010;98(3):417-9.
2010: Thomas Skripuletz; Jens-Heiko Bussmann; Viktoria Gudi; Paraskevi N Koutsoudaki; Refik Pul; Darius Moharregh-Khiabani; Maren Lindner; Martin Stangel
Cerebellar cortical demyelination in the murine cuprizone model.
Brain pathology (Zurich, Switzerland) 2010;20(2):301-12.
2010: Darius Moharregh-Khiabani; Alexander Blank; Thomas Skripuletz; Elvira Miller; Alexandra Kotsiari; Viktoria Gudi; Martin Stangel
Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse.
PloS one 2010;5(7):e11769.
2010: Corinna Trebst; Elke Voss; Thomas Skripuletz; Martin Stangel
Specific immune intervention with monoclonal antibodies for the treatment of multiple sclerosis.
Current medicinal chemistry 2010;17(7):640-50.
2009: Seza Bolat; Georg Berding; Reinhard Dengler; Martin Stangel; Corinna Trebst
Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis.
Journal of the neurological sciences 2009;287(1-2):257-9.
2009: R Pul; T Kopadze; Thomas Skripuletz; E V Voss; B C Kieseier; Martin Stangel
Polyclonal immunoglobulins (IVIg) induce expression of MMP-9 in microglia.
Journal of neuroimmunology 2009;217(1-2):46-50.
2009: D Ragancokova; K Jahn; A Kotsiari; Friedrich Schlesinger; Kirsten Haastert; Martin Stangel; Susanne Petri; Klaus Krampfl
Analysis of neuroprotective effects of valproic acid on primary motor neurons in monoculture or co-cultures with astrocytes or Schwann cells.
Cellular and molecular neurobiology 2009;29(6-7):1037-43.
2009: Viktoria Gudi; Darius Moharregh-Khiabani; Thomas Skripuletz; Paraskevi N Koutsoudaki; Alexandra Kotsiari; Jelena Skuljec; Corinna Trebst; Martin Stangel
Regional differences between grey and white matter in cuprizone induced demyelination.
Brain research 2009;1283():127-38.
2009: Martin Stangel
Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hype.
Nature reviews. Neurology 2009;5(6):300-2.
2009: Martin Stangel; H-P Hartung; R Gold; B C Kieseier
[The significance of intravenous immunoglobulin in treatment of immune-mediated polyneuropathies].
Der Nervenarzt 2009;80(6):678-87.
2009: Maren Lindner; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
Neuroscience letters 2009;453(2):120-5.
2009: D Moharregh-Khiabani; R A Linker; R Gold; Martin Stangel
Fumaric Acid and its esters: an emerging treatment for multiple sclerosis.
Current neuropharmacology 2009;7(1):60-4.
2009: Paraskevi N Koutsoudaki; Thomas Skripuletz; Viktoria Gudi; Darius Moharregh-Khiabani; Herbert Hildebrandt; Corinna Trebst; Martin Stangel
Demyelination of the hippocampus is prominent in the cuprizone model.
Neuroscience letters 2009;451(1):83-8.
2009: Corinna Trebst; Ansgar Reising; Jan T Kielstein; Carsten Hafer; Martin Stangel
Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis.
Blood purification 2009;28(2):108-15.
2009: C Werry; F Götz; Ulrich Wurster; Martin Stangel; Ralf Giess; Fedor Heidenreich; Anja Windhagen
Paraneoplastic autoimmune encephalitis associated with CV2/CRMP-5 IgG antineuronal antibodies in a patient with thymoma.
Journal of neurology 2009;256(1):129-31.
2008: Martin Stangel
Neuroprotection and neuroregeneration in multiple sclerosis.
Journal of neurology 2008;255 Suppl 6():77-81.
2008: Ralf A Linker; De-Hyung Lee; Martin Stangel; Ralf Gold
Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies.
Expert review of neurotherapeutics 2008;8(11):1683-90.
2008: Martin Stangel
New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins.
Therapeutic advances in neurological disorders 2008;1(2):52-61.
2008: Refik Pul; Martin Stangel
Using immunoglobulins in muscular disease treatment.
Expert opinion on biological therapy 2008;8(8):1143-50.
2008: Maren Lindner; Corinna Trebst; Sandra Heine; Thomas Skripuletz; Paraskevi N Koutsoudaki; Martin Stangel
The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination.
Glia 2008;56(10):1104-13.
2008: Corinna Trebst; F König; Rm Ransohoff; W Brück; Martin Stangel
CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(6):728-33.
2008: Thomas Skripuletz; Maren Lindner; Alexandra Kotsiari; Niklas Garde; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
The American journal of pathology 2008;172(4):1053-61.
2008: Katrin Hoffmann; Maren Lindner; Ina Gröticke; Martin Stangel; Wolfgang Löscher
Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice.
Experimental neurology 2008;210(2):308-21.
2008: Elke Wiesemann; Milani Deb; Corinna Trebst; Bernhard Hemmer; Martin Stangel; Anja Windhagen
Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(2):166-76.
2008: Martin Stangel; D Moharregh-Khiabani; R A Linker; R Gold
[Fumaric acid and its esters in the treatment of multiple sclerosis: studies and effects].
Der Nervenarzt 2008;79(2):212-7.
2008: Maren Lindner; Sandra Heine; Kirsten Haastert; N Garde; J Fokuhl; F Linsmeier; Claudia Grothe; W Baumgärtner; Martin Stangel
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Neuropathology and applied neurobiology 2008;34(1):105-14.
2008: Nico Melzer; Sven G Meuth; Delany Torres-Salazar; Stefan Bittner; Alla L Zozulya; Christian Weidenfeller; Alexandra Kotsiari; Martin Stangel; Christoph Fahlke; Heinz Wiendl
A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis.
PloS one 2008;3(9):e3149.
2007: Corinna Trebst; Sandra Heine; Stefan Lienenklaus; Maren Lindner; Wolfgang Baumgärtner; Siegfried Weiss; Martin Stangel
Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination.
Acta neuropathologica 2007;114(6):587-96.
2007: Corinna Trebst; Hans Heiken; Reinhold E Schmidt; Anja Windhagen; Martin Stangel
Delta32 polymorphism of the chemokine receptor CCR5 in a patient with multifocal motor neuropathy.
Muscle & nerve 2007;35(4):541-2.
2007: Ralf Gold; Martin Stangel; Marinos C Dalakas
Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
Nature clinical practice. Neurology 2007;3(1):36-44.
2006: Corinna Trebst; K Brunhorn; Maren Lindner; Anja Windhagen; Martin Stangel
Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulins.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(12):1359-63.
2006: Frauke Zipp; H P Hartung; J Hillert; Sebastian Schimrigk; Corinna Trebst; Martin Stangel; Carmen Infante-Duarte; Peter Jakobs; Christian Wolf; Rupert Sandbrink; C Pohl; M Filippi
Blockade of chemokine signaling in patients with multiple sclerosis.
Neurology 2006;67(10):1880-3.
2006: Martin Stangel; Refik Pul
Basic principles of intravenous immunoglobulin (IVIg) treatment.
Journal of neurology 2006;253 Suppl 5():V18-24.
2006: Martin Stangel
Does natalizumab have a role in the treatment of relapsing multiple sclerosis?
Nature clinical practice. Neurology 2006;2(9):476-7.
2006: Samaneh Maysami; Dan Nguyen; Franziska Zobel; Sandra Heine; Michael Höpfner; Martin Stangel
Oligodendrocyte precursor cells express a functional chemokine receptor CCR3: implications for myelination.
Journal of neuroimmunology 2006;178(1-2):17-23.
2006: Sandra Heine; Jens Ebnet; Samaneh Maysami; Martin Stangel
Effects of interferon-beta on oligodendroglial cells.
Journal of neuroimmunology 2006;177(1-2):173-80.
2006: Samaneh Maysami; Dan Nguyen; Franziska Zobel; Caroline Pitz; Sandra Heine; Michael Höpfner; Martin Stangel
Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12.
Neuroreport 2006;17(11):1187-90.
2006: Martin Stangel; Corinna Trebst
Remyelination strategies: new advancements toward a regenerative treatment in multiple sclerosis.
Current neurology and neuroscience reports 2006;6(3):229-35.
2006: Martin Stangel; Ralf Gold; Achim Gass; Judith Haas; Stefan Jung; Wolfgang Elias; Uwe K Zettl
Current issues in immunomodulatory treatment of multiple sclerosis--a practical approach.
Journal of neurology 2006;253 Suppl 1():I32-6.
2006: Corinna Trebst; H Wiendl; Martin Stangel
[Concepts of lesion development in multiple sclerosis. Current approaches and clinical-therapeutic implications ].
Der Nervenarzt 2006;77(2):158, 160-2, 164.
2006: Corinna Trebst; Martin Stangel
Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis.
Current pharmaceutical design 2006;12(2):241-9.
2005: Martin Stangel; R Gold
[High-dose intravenous immunoglobulins in the treatment of multiple sclerosis. An update].
Der Nervenarzt 2005;76(10):1267, 1269-70, 1272.
2005: Corinna Trebst; Martin Stangel
[Cannabinoids in multiple sclerosis -- therapeutically reasonable?].
Fortschritte der Neurologie-Psychiatrie 2005;73(8):463-9.
2005: Martin Stangel; R Gold
Intravenous Immunoglobulins in MS.
International MS journal / MS Forum 2005;12(1):5-10, 4.
2004: S Marckmann; Elke Wiesemann; R Hilse; Corinna Trebst; Martin Stangel; Anja Windhagen
Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Clinical and experimental immunology 2004;138(3):499-506.
2004: Martin Stangel; R Gold
[Use of i.v. immunoglobulins in neurology. Evidence-based consensus].
Der Nervenarzt 2004;75(8):801-15.
2004: Martin Stangel
Remyelinating and neuroprotective treatments in multiple sclerosis.
Expert opinion on investigational drugs 2004;13(4):331-47.
2003: Dan Nguyen; Michael Höpfner; Franziska Zobel; Uta Henke; Hans Scherübl; Martin Stangel
Rat oligodendroglial cell lines express a functional receptor for the chemokine CCL3 (macrophage inflammatory protein-1alpha).
Neuroscience letters 2003;351(2):71-4.
2003: Corinna Trebst; R M Ransohoff; Anja Windhagen; Martin Stangel
[Chemokine--possible new options for the treatment of multiple sclerosis].
Der Nervenarzt 2003;74(10):850-7.
2003: Martin Stangel; Reinhard Kiefer; Martin Pette; Michael N Smolka; Peter Marx; Ralf Gold
Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study.
Journal of neurology 2003;250(7):818-21.
2003: Martin Stangel; Dirk Bernard
Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination.
Journal of neuroimmunology 2003;138(1-2):25-30.
2002: Martin Stangel; Hans-Peter Hartung
Remyelinating strategies for the treatment of multiple sclerosis.
Progress in neurobiology 2002;68(5):361-76.
2002: Refik Pul; Dan Nguyen; Ulrike Schmitz; Peter Marx; Martin Stangel
Comparison of intravenous immunoglobulin preparations on microglial function in vitro: more potent immunomodulatory capacity of an IgM/IgA-enriched preparation.
Clinical neuropharmacology 2002;25(5):254-9.
2002: Anne-Christine Karow; Jürgen Braun; Peter Marx; Martin Stangel
Remission of a CNS inflammatory disease accompanied by newly developed ANA and arthropathy during treatment with IFN-beta.
Journal of neurology 2002;249(8):1121-2.
2001: Martin Stangel; E Mix; Uwe K Zettl; R Gold
Oxides and apoptosis in inflammatory myopathies.
Microscopy research and technique 2001;55(4):249-58.
2001: Dan Nguyen; Martin Stangel
Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells.
Brain research. Developmental brain research 2001;128(1):77-81.
2001: Martin Stangel; A Compston
Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors.
Journal of neuroimmunology 2001;112(1-2):63-71.
2000: Martin Stangel; F Boegner; C H Klatt; Christoph Hofmeister; Sepp Seyfert
Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2000;68(1):89-92.
1999: Martin Stangel; Christian Stapf; Peter Marx
Presentation and prognosis of bilateral infarcts in the territory of the superior cerebellar artery.
Cerebrovascular diseases (Basel, Switzerland) 1999;9(6):328-33.
1998: Martin Stangel; M Müller; Peter Marx
Adverse events during treatment with high-dose intravenous immunoglobulins for neurological disorders.
European neurology 1998;40(3):173-4.
1998: Martin Stangel; K T Vogeley; Claudia Jandeck; F Boegner; Peter Marx; Hans Christian Koch
[Septo-optic dysplasia (de Morsier syndrome)].
Der Nervenarzt 1998;69(4):352-6.
1998: Martin Stangel; H P Hartung; Peter Marx; R Gold
Intravenous immunoglobulin treatment of neurological autoimmune diseases.
Journal of the neurological sciences 1998;153(2):203-14.
1997: Martin Stangel; A Lüchow; Christian Stapf; Peter Marx; J P Mohr; Henning Mast
Cerebellar atrophy with basilar artery occlusion.
European journal of medical research 1997;2(10):428-30.
1997: Martin Stangel; H P Hartung; Peter Marx; R Gold
Side effects of high-dose intravenous immunoglobulins.
Clinical neuropharmacology 1997;20(5):385-93.
1997: Martin Stangel; Hermann Schumacher; K Ruprecht; F Boegner; Peter Marx
Immunoglobulins for intravenous use inhibit TNF alpha cytotoxicity in vitro.
Immunological investigations 1997;26(5-7):569-78.
1997: Uwe K Zettl; Eilhard Mix; J Zielasek; Martin Stangel; H P Hartung; R Gold
Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro.
Cellular immunology 1997;178(1):1-8.
1996: Martin Stangel; F Boegner
[A quickly reversible occlusion in the vertebrobasilar circulatory bed: often unrecognized?].
Deutsche medizinische Wochenschrift (1946) 1996;121(37):1123-6.